Recent Quotes (30 days)

You have no recent quotes
chg | %

Crispr Therapeutics AG financials

   Watch this stock
In Millions of USD (except for per share items) 3 months ending 2017-09-30 3 months ending 2017-06-30 3 months ending 2017-03-31 3 months ending 2016-12-31 3 months ending 2016-09-30
Revenue 2.39 3.58 2.70 2.34 1.55
Other Revenue, Total - - - - -
Total Revenue 2.39 3.58 2.70 2.34 1.55
Cost of Revenue, Total - - - - -
Gross Profit - - - - -
Selling/General/Admin. Expenses, Total 8.11 7.77 8.64 12.08 4.11
Research & Development 17.84 17.12 14.80 15.57 12.05
Depreciation/Amortization - - - - -
Interest Expense(Income) - Net Operating - - - - -
Unusual Expense (Income) 0.00 0.00 0.00 0.00 0.00
Other Operating Expenses, Total - - - - -
Total Operating Expense 25.96 24.89 23.45 27.65 16.16
Operating Income -23.57 -21.31 -20.74 -25.31 -14.61
Interest Income(Expense), Net Non-Operating - - - - -
Gain (Loss) on Sale of Assets - - - - -
Other, Net -0.07 -0.16 -0.01 78.65 -0.07
Income Before Tax -24.00 -21.97 -21.20 17.50 -14.69
Income After Tax -24.71 -22.32 -21.48 17.10 -14.69
Minority Interest - 0.00 0.00 0.00 0.01
Equity In Affiliates - - - - -
Net Income Before Extra. Items -24.71 -22.32 -21.48 17.10 -14.68
Accounting Change - - - - -
Discontinued Operations - - - - -
Extraordinary Item - - - - -
Net Income -24.71 -22.32 -21.48 17.10 -14.68
Preferred Dividends - - - - -
Income Available to Common Excl. Extra Items -24.71 -22.32 -21.48 17.10 -14.68
Income Available to Common Incl. Extra Items -24.71 -22.32 -21.48 17.10 -14.68
Basic Weighted Average Shares - - - - -
Basic EPS Excluding Extraordinary Items - - - - -
Basic EPS Including Extraordinary Items - - - - -
Dilution Adjustment - - - - -
Diluted Weighted Average Shares 40.09 39.90 39.73 12.26 39.75
Diluted EPS Excluding Extraordinary Items -0.62 -0.56 -0.54 1.39 -0.37
Diluted EPS Including Extraordinary Items - - - - -
Dividends per Share - Common Stock Primary Issue 0.00 0.00 0.00 - 0.00
Gross Dividends - Common Stock - - - - -
Net Income after Stock Based Comp. Expense - - - - -
Basic EPS after Stock Based Comp. Expense - - - - -
Diluted EPS after Stock Based Comp. Expense - - - - -
Depreciation, Supplemental - - - - -
Total Special Items - - - - -
Normalized Income Before Taxes - - - - -
Effect of Special Items on Income Taxes - - - - -
Income Taxes Ex. Impact of Special Items - - - - -
Normalized Income After Taxes - - - - -
Normalized Income Avail to Common - - - - -
Basic Normalized EPS - - - - -
Diluted Normalized EPS -0.62 -0.56 -0.54 1.39 -0.37